Yahoo Web Search

Search results

1. • 

     Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know

     Zacks via Yahoo Finance· 5 hours ago

     Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $397.70, moving -0.76% from the...

2. • 

     2 Fantastic Growth Stocks to Buy Right Now

     Motley Fool via Yahoo Finance· 13 hours ago

     On that note, here are two fantastic growth stocks to consider putting cash into the next time you go shopping for businesses to add to your basket of...

3. • 

     (VRTX) - Analyzing Vertex Pharmaceuticals's Short Interest By Benzinga

     Investing.com· 8 hours ago

     Vertex Pharmaceuticals's (NYSE:VRTX) short percent of float has fallen 3.75% since its last report....

4. • 

     Vertex selected to join Oracle ISV Accelerator for SaaS Initiative

     The Accountant via Yahoo Finance· 13 hours ago

     Vertex, a global provider of tax technology solutions and a member of Oracle PartnerNetwork (OPN),...

5. • Sigma Planning Corp Sells 1,061 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

     ETF DAILY NEWS· 20 hours ago

     Sigma Planning Corp cut its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 37.3% during the 4th quarter, according to its most recent Form ...

6. • In a Transformative Year, Vertex Advances Its Commitment to Corporate Responsibility; Announces 2023...

     3BL CSRwire· 13 hours ago

     2023 was a transformative year for Vertex. The company made significant advances toward delivering on its core mission of creating transformative medicines for people with ...

7. • 

     Is Vertex Pharmaceuticals Stock a Millionaire Maker?

     Motley Fool via Yahoo Finance· 7 days ago

     Vertex Pharmaceuticals (NASDAQ: VRTX) is a growing pharmaceutical company with a robust cystic fibrosis (CF) business that generated nearly $10 billion...

8. • Vertex (NASDAQ:VERX) Price Target Cut to $32.00

     ETF DAILY NEWS· 24 hours ago

     A number of other research firms have also issued reports on VERX. The Goldman Sachs Group raised their price target on shares of Vertex from $33.00 to $39.00 and gave the ...

9. • Vertex Pharmaceuticals (NASDAQ:VRTX) PT Lowered to $466.00 at UBS Group

     ETF DAILY NEWS· 6 days ago

     Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price target cut by UBS Group from $498.00 to $466.00 in a report published on Wednesday morning, Benzinga reports ...

10. • Vertex (NASDAQ:VERX) Shares Gap Down on Analyst Downgrade

      ETF DAILY NEWS· 1 day ago

      Shares of Vertex, Inc. (NASDAQ:VERX – Get Free Report) gapped down prior to trading on Tuesday after Citigroup lowered their price target on the stock from $34.00 to $32.00 ...